Table 2 Relationship between CSMD1 expression and clinical features of patients with hepatocellular carcinoma

Age (years)

  ≤ 52 (n = 68)

19

49

0.026

0.872

  > 52 (n = 60)

16

44

Sex

 Male (n = 108)

29

79

0.084

0.772

 Female (n = 20)

6

14

AFP

  ≥ 20 ng/mL (n = 76)

21

55

0.008

0.930

  < 20 ng/mL (n = 52)

14

38

HBsAg or HCV

  + (n = 86)

24

62

0.042

0.838

 - (n = 42)

11

31

HCC differentiation

 Grade I (n = 14)

6

8

2.856

0.240

 Grade II (n = 78)

22

56

 Grade III (n = 36)

7

29

Tumor size

  ≥ 5 cm (n = 68)

20

48

0.312

0.576

  < 5 cm (n = 60)

15

45

Extrahepatic metastasis

 Presence (n = 42)

11

31

0.042

0.838

 Absence (n = 86)

24

62